https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-05-01 / J. Immunother. 2009 May;32(4):363-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-05-01 / J. Immunother. 2009 May;32(4):363-92009-05-01 00:00:002019-02-15 08:44:23Conditioning vaccination site with irradiated MIP-3alpha-transfected tumor cells enhances efficacy of dendritic cell-based cancer vaccine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-05-01 / Expert Rev Vaccines 2009 May;8(5):567-76
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-05-01 / Expert Rev Vaccines 2009 May;8(5):567-762009-05-01 00:00:002019-02-15 08:44:24Novel strategies for improved cancer vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-05-01 / Expert Opin Biol Ther 2009 May;9(5):539-64
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-05-01 / Expert Opin Biol Ther 2009 May;9(5):539-642009-05-01 00:00:002019-02-15 08:44:25Dendritic cells: therapy and imaging
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-05-01 / Hum. Immunol. 2009 May;70(5):331-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-05-01 / Hum. Immunol. 2009 May;70(5):331-92009-05-01 00:00:002019-02-15 09:19:12Melanoma vaccines: The problems of local immunosuppression
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-04-15 / J. Cell. Biochem. 2009 Apr;106(6):999-1009
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-04-15 / J. Cell. Biochem. 2009 Apr;106(6):999-10092009-04-15 00:00:002019-02-15 09:17:34Nitric oxide-mediated inhibition of NFkappaB regulates hyperthermia-induced apoptosis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-04-11 / Urol. Oncol. 2010 May-Jun;28(3):290-5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-04-11 / Urol. Oncol. 2010 May-Jun;28(3):290-52009-04-11 00:00:002019-02-15 08:53:01Tumor specific cytotoxicity and telomerase down-regulation in prostate cancer by autologous dendritic cells loaded with whole tumor cell antigens
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-04-10 / Cancer Immunol. Immunother. 2009 Jul;58(7):1169-74
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-04-10 / Cancer Immunol. Immunother. 2009 Jul;58(7):1169-742009-04-10 00:00:002019-02-15 08:48:09Vaccination strategies in patients with renal cell carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-04-08 / Eur. J. Cancer 2009 Jul;45(11):1969-78
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-04-08 / Eur. J. Cancer 2009 Jul;45(11):1969-782009-04-08 00:00:002019-02-15 08:35:44Hyperthermia dose-effect relationship in 420 patients with cervical cancer treated with combined radiotherapy and hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-04-01 / Expert Opin Investig Drugs 2009 Apr;18(4):509-19
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-04-01 / Expert Opin Investig Drugs 2009 Apr;18(4):509-192009-04-01 00:00:002019-02-15 08:46:47DCVax-Brain and DC vaccines in the treatment of GBM
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-04-01 / Int. J. Radiat. Oncol. Biol. Phys. 2009 Apr;73(5):1538-44
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-04-01 / Int. J. Radiat. Oncol. Biol. Phys. 2009 Apr;73(5):1538-442009-04-01 00:00:002019-02-15 09:17:35Use of the concept of equivalent biologically effective dose (BED) to quantify the contribution of hyperthermia to local tumor control in radiohyperthermia cervical cancer trials, and comparison with radiochemotherapy results
